{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:06:44Z","timestamp":1756339604497,"version":"3.44.0"},"reference-count":9,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,11,16]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>Regional ischaemic immune myopathy (RIIM) is a subtype of dermatomyopathy which has distinct histopathology features of regional muscle fibre necrosis and regeneration. This case report aims to provide an in-depth exploration of RIIM, emphasising its clinical features and the crucial role of muscle biopsy as a diagnostic investigation, as well as the potential role of immunomodulatory therapies.<\/jats:p>","DOI":"10.1136\/bcr-2024-260865","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T20:35:12Z","timestamp":1734294912000},"page":"e260865","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Regional ischaemic immune myopathy: unraveling a rare subtype of dermatomyopathy"],"prefix":"10.1136","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9045-1037","authenticated-orcid":false,"given":"Elvina","family":"Ingrid","sequence":"first","affiliation":[{"name":"Rheumatology, Western Health, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona","family":"McLean","sequence":"additional","affiliation":[{"name":"Anatomical Pathology Department, Victorian Neuromuscular Laboratory, Alfred Health, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maninder","family":"Mundae","sequence":"additional","affiliation":[{"name":"Rheumatology, Western Health, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Lim","sequence":"additional","affiliation":[{"name":"Rheumatology, Western Health, Melbourne, Victoria, Australia"},{"name":"Medicine, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,12,15]]},"reference":[{"key":"2025082712441682000_17.12.e260865.1","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/NEN.0000000000000132","article-title":"Regional Ischemic Immune Myopathy: A Paraneoplastic Dermatomyopathy","volume":"73","author":"Cai","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"2025082712441682000_17.12.e260865.2","doi-asserted-by":"crossref","unstructured":"Granger A , Soontrapa P , Klein C , et al . Cancer-associated Regional Ischemic Myopathy: A Rare Immune Myopathy (P9-8.008). Neurology (ECronicon) 2023;100. doi:10.1212\/WNL.0000000000203371","DOI":"10.1212\/WNL.0000000000203371"},{"key":"2025082712441682000_17.12.e260865.3","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000434","article-title":"Immune myopathies with perimysial pathology: Clinical and laboratory features","volume":"5","author":"Bucelli","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025082712441682000_17.12.e260865.4","doi-asserted-by":"crossref","unstructured":"Findlay AR , Bucelli RC . Immune and Inflammatory Myopathies. Neuroimmunol 2021;321\u201345. doi:10.1007\/978-3-030-61883-4_20","DOI":"10.1007\/978-3-030-61883-4_20"},{"key":"2025082712441682000_17.12.e260865.5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnen\/nlab071","article-title":"Pathology Features of Immune and Inflammatory Myopathies, Including a Polymyositis Pattern, Relate Strongly to Serum Autoantibodies","volume":"80","author":"Pestronk","year":"2021","journal-title":"J Neuropathol Exp Neurol"},{"key":"2025082712441682000_17.12.e260865.6","unstructured":"Pestronk A . Neuromuscular disease center. 2024. Available: https:\/\/neuromuscular.wustl.edu\/antibody\/infmyop.htm#malignancy"},{"key":"2025082712441682000_17.12.e260865.7","first-page":"e739","article-title":"Dermatomyositis: Muscle Pathology According to Antibody Subtypes","volume":"98","author":"Tanboon","year":"2022","journal-title":"Neurology (ECronicon)"},{"key":"2025082712441682000_17.12.e260865.8","unstructured":"Pestronk A . Neuromuscular disease center 2024. 2024 Available: https:\/\/neuromuscular.wustl.edu\/pathol\/jo1.htm"},{"key":"2025082712441682000_17.12.e260865.9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41584-023-01045-w","article-title":"International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative","volume":"19","author":"Oldroyd","year":"2023","journal-title":"Nat Rev Rheumatol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-260865","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T19:44:22Z","timestamp":1756323862000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-260865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":9,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,15]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/bcr-2024-260865"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-260865","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}